OrSense is a medical device company developing and marketing non-invasive monitoring systems for measurement of Hemoglobin. OrSense NBM200 system is successfully installed in dozens of blood donation facilities worldwide. OrSense's products are based on a proprietary Occlusion Spectroscopy technology.
www.orsense.com
www.orsense.com
Location: Israel, Central, Petah Tikva
Employees: 11-50
Total raised: $18M
Founded date: 1997
Investors 1
| Date | Name | Website |
| - | Israel Hea... | ihcv.co.il... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.05.2011 | - | $18M | - |
Mentions in press and media 3
| Date | Title | Description |
| 28.06.2012 | Bloodless glucometer uses light to check blood sugar in 20 seconds or less | Grove is one of several companies working on a noninvasive diabetes test using spectroscopy including DIRAmed, C8 MediSensors and InLight Solutions. Challenges in developing devices using this technique have included water interference and ... |
| 02.05.2011 | OrSense Closes U.S.$18M Financing | OrSense Ltd., a Ness Ziona, Israel-based developer of monitors for non-invasive measurements of key blood parameters, closed a U.S.$18m financing. The round was led by Israel Healthcare Ventures, with participation from IHCV, STAR Ventures ... |
| - | Bloodless glucometer uses light to check blood sugar in 20 seconds or less | When will diabetics in the U.S. get a bloodless glucometer that will allow them to check their blood sugar without a finger prick? The short answer is, we don’t know for sure. But a company that’s wrapped up initial testing of its bloodless... |